ArticleThe American journal of gastroenterology2015
Combination therapy with sorafenib and radiofrequency ablation for BCLC stage 0-B1 hepatocellular carcinoma.
Tian Yang et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it